Clinical value of serum CA 125, CA 19 - 9 and CA 72 - 4 combined determination in diagnosis of ovary tumor
- Author:
- No author available
- Journal Title:
- CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
- Issue:
- 2
- DOI:
- 10.3760/cma.j.issn.1008-6706.2011.02.004
- Key Word:
- 卵巢肿瘤;肿瘤标记,生物学;Ovarian neoplasms;Tumor markers,biological
Abstract： Objective To explore the clinical value of serum CA125, CA19-9 and CA72-4 in ovary epithelial tumor and ovary endometriosis. Methods The detection results of ovary epithelial benign (n = 28) and malignant tumors (n = 15) and ovary endometriosis (n = 42) were retrospectively reviewed and compared with the results of 30 healthy women. Results The expression value of serum CA125 ,CA19-9 and CA72-4 in ovary epithelial cancers was obviously higher than others(all P ＜0.05). And the expression value of serum CA125 ,CA19-9 and CA72-4 in ovary endometriosis was higher than that of ovary benign tumors and the normal group (all P ＜ 0.05). Positive rate of combined determination was higher than that of single marker(P ＜0.05). Conclusion The detection of serum CA125,CA19-9 and CA72-4 had great significance in the diagnosis of ovary epithelial cancers. It could also be used in the diagnosis of ovary endometriosis.
- [1]沈智君,余剑敏,万雄萍.血清CA125 CA199在妇科盆腔肿瘤中的表达及意义[J].2010,(6).
- [2]祁玉兰,张永红,马彩玲.肿瘤标志物联合超声在卵巢肿瘤诊断中的价值[J].2009,(10).
- [3]郑阳.卵巢上皮癌与卵巢子宫内膜异位囊肿血清LSA、CA125的测定[J].2008,(12).
- [4]余剑英,李菁.血清CA125、CA199在卵巢浆、粘液性囊腺癌术前诊断价值[J].2004,(10).
- [5]李山,秦雪,何卫华.血清CA125在卵巢癌诊断中的价值及文献评价[J].2005,(2).
- [6]单丹.联合检测肿瘤标志物在卵巢肿瘤筛查中的意义[J].2010,(24).
- [7]董丽,崔恒,李小平,等.CA19-9、CA125和CP2在卵巢黏液性肿瘤诊断和监测中的价值[J].2008,(1).
- [8]徐永成,孙敏,陈奇奥.血清CA125、CA19-9、CA72-4和EMA联检对卵巢癌的诊断价值[J].2007,(5).
- [9]栾晓蕊,李卫平,狄文.卵巢癌早期诊断的血清肿瘤标志物研究进展[J].2009,(6).
- [10]张淑兰,王丹波,任凤岩.肿瘤标志物检测在复发性卵巢癌诊治中的意义[J].2005,(7).
- [11]李宣海,巫向前,倪语星主编.肿瘤标志物的检测与临床[M].1997.
- [12]高玉香,刘诚明.血清肿瘤标志CA125、CA724在卵巢癌诊断中的应用[J].2009,(20).